辰欣藥業(603367.SH):斥2000萬元設立濟南辰欣醫藥
格隆匯 7 月 31日丨辰欣藥業(603367.SH)公佈,根據公司發展戰略,結合公司未來研發戰略發展和業務佈局的需要,公司以自有資金出資設立濟南辰欣醫藥科技有限公司,註冊資本人民幣2000萬元,目前,濟南辰欣醫藥已辦理工商註冊登記手續,並於近日取得了濟南高新技術產業開發區管委會市場監管局頒發的《營業執照》。
濟南辰欣醫藥科技有限公司(“濟南辰欣醫藥”)經營範圍:一般項目:技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;化工產品銷售(不含許可類化工產品);生物化工產品技術研發(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)
公司此次投資設立全資子公司短期內不會對公司經營業績、生產經營活動產生重大影響;長期來看,此次投資有利於公司在產品研發、註冊、銷售等方面開展戰略分工合作等方式,提高公司資源、資本和資產的利用效率、降低項目成本與投資風險,有利於為公司及全體股東創造中長期、可持續的價值收益。符合公司發展戰略和全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.